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Understanding the complex process by which the invasive form of the Plasmodium falciparum 
parasite, the merozoite, attaches to and invades erythrocytes as part of its blood stage life cycle 
represents a key area of research in the battle to combat malaria. Central to this are efforts to 
determine the identity of receptors on the host cell surface, their corresponding merozoite binding 
proteins and the functional relevance of these binding events as part of the invasion process. This 
review will provide an updated summary of studies identifying receptor interactions essential for or 
implicated in P. falciparum merozoite invasion of human erythrocytes, highlighting the recent 
identification of new receptors using groundbreaking high throughput approaches and with 
particular focus on the properties and putative involvement of the erythrocyte proteins targeted by 
these invasion pathways. 
Abstract 
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Despite significant progress over the last decade, annual cases of malaria continue to number in the 
hundreds of millions resulting in up to half a million deaths every year (
Introduction 
WHO, 2014). Malaria is 
caused by infection by parasites of the genus Plasmodium within the phylum apicomplexa. Five 
species of Plasmodium are capable of infecting humans, however despite justified concerns 
regarding increased incidence of Plasmodium vivax infection (Galinski and Barnwell, 2008) and the 
emergence of Plasmodium knowlesi (Singh et al., 2004), Plasmodium falciparum remains the major 
source of morbidity associated with this parasite (Snow et al., 2005). 
P. falciparum exhibits a complex life cycle which includes stages within the Anopheles mosquito 
vector and the hepatocytes of the human liver. The manifestation of symptoms and the burden of 
morbidity associated with malaria however occur almost entirely as a result of the asexual 
replication cycle that takes place within circulating erythrocytes (red blood cells). This rapid 
replication cycle, which follows initial invasion of an erythrocyte host cell takes approximately 42-48 
hours and is characterised by multiplication and maturation of the parasite through so called ring 
stages, trophozoites and schizonts and culminates in eventual rupture of the erythrocyte releasing 
up to 32 new merozoites each of which is capable of rapidly infecting a new red blood cell. As the 
only extracellular stage of the parasite life cycle within the human host and with a view to 
development of an effective therapeutic vaccine, the process by which merozoites attach to and 
invade erythrocytes has provided a focus of malaria research for many years.  
This review will summarise past and recent successes in determining the identity of receptors on the 
red blood cell surface that are essential for or implicated in P. falciparum merozoite invasion of 
human erythrocytes; highlight the structural and functional properties of these host proteins and 
provide speculation regarding their relevance as part of the merozoite invasion process. 
Blood stage invasion by the malarial parasite begins with the interaction between a merozoite (the 
invasive form of the parasite) and the erythrocyte surface. The interaction can occur irrespective of 
the orientation of the merozoite and most commonly begins as a ‘side on’ association. This initial 
low affinity and reversible interaction elicits waves of deformation of the erythrocyte membrane 
(
The process of merozoite invasion 
Weiss et al., 2015) and is swiftly followed by reorientation of the merozoite such that the apical tip 
is in direct contact with the host membrane. Direct high affinity interactions established between 
membrane proteins expressed on the erythrocyte surface and merozoite adhesins such as the EBL 
(Erythrocyte Binding Ligand) and PfRh (P. falciparum Reticulocyte binding Homolog) proteins commit 
the parasite to active invasion which proceeds through an induced depression in the erythrocyte 
surface and is mediated by the formation of a ‘tight junction’ defined by merozoite proteins of the 
AMA1-RON complex inserted into the erythrocyte membrane. Penetrative force provided by the 
parasite actin myosin motor drives the merozoite across the host membrane into a parasitophorous 
vacuole compartment believed to be created by secretion of the rhoptries into the host cell and the 
erythrocyte membrane is resealed completing the process. This entire sequence of events is 
completed within approximately 30 seconds and the current model is summarised in Figure 1. 
 
4 
 
Merozoites can use different pathways, defined by receptor–ligand interactions, for invasion of 
erythrocytes. Traditionally within the malaria field invasion by P. falciparum has been classified as 
occurring via two main pathways – sialic acid (SA) dependent and SA independent invasion, 
characterised by the capacity to invade erythrocytes in which sialic acid has been cleaved using the 
protease neuraminidase. Sialic acid dependent invasion involves the erythrocyte glycophorin binding 
proteins, EBA175, EBL-1 and EBA140 discussed in greater detail below as well EBA181 and PfRh1 
which have been demonstrated to bind SA but of as yet unidentified receptor. Sialic acid 
independent invasion is predominantly believed to be reliant on the neuraminidase insensitive 
binding of PfRh4. 
Alternate Invasion Pathways 
Different strains of P. falciparum, both clinical isolates and defined lab adapted clones vary in their 
dependence on sialated erythrocyte receptors for invasion. Functional redundancy within the 
repertoire of merozoite erythrocyte binding proteins such as the SA binding EBA family allied to 
variation in the expression or use of such proteins provide the parasite with powerful mechanisms 
by which to evade the development and efficacy of inhibitory antibodies by the immune system. 
However perhaps the most striking demonstration of the adaptability of plasmodium comes from 
the elegant work of Stubbs et al who demonstrated the capacity for sialic acid dependent parasites 
to reversibly switch to a SA independent invasion pathway via activation of PfRh4 expression in 
response to the removal of target erythrocytes sialic acid (by neuraminidase) or by genetic ablation 
of EBA175 (Stubbs et al., 2005). This illustration of the “plasticity of P. falciparum
Stubbs et al., 2005
 in the face of 
selective pressures such as altered erythrocyte receptors” ( ) highlights the 
challenges faced by efforts to develop an effective vaccine to combat malaria erythrocyte invasion. 
Sialic Acid Dependent Invasion Receptors 
Glycophorin A is a 131 amino acid type I transmembrane glycoprotein, expression of which is 
restricted to the erythroid lineage of cells. Together with the chloride bicarbonate transporter band 
3 it represents the most abundant protein within the erythrocyte membrane, present at 
approximately 1x10
Glycophorin A (EBA175) 
6 Reid ME, 2012 copies per cell ( ). It is the major erythrocyte sialoglycoprotein in 
the erythrocyte membrane, existing as a heavily glycosylated transmembrane dimer with one N 
glycan and at least 15 O glycans per monomer. Although it exists predominantly as homodimers, 
GPA is also capable of forming heterodimers with glycophorin B and interacts directly with the 
eighth transmembrane helix of band 3 (forming the dual protein blood group antigen Wrb) (Telen 
and Chasis, 1990) and via its C-terminus. Glycophorin A was the first erythrocyte receptor for which 
a corresponding P. falciparum ligand was identified and is bound by the micronemal erythrocyte 
binding protein EBA175 (Orlandi et al., 1992). Interaction between these two proteins has now been 
extensively characterised, with the binding site on GPA mapped to sialylated glycan epitopes within 
the region of the N terminal domain covered by amino acids 55-72, which is bound by the RII domain 
of EBA175(Tolia et al., 2005). Structural analysis suggests that the RII domain of EBA175 assembles 
as a dimer around the dimeric GPA extracellular domain in response to binding of the parasite 
protein to its erythrocyte receptor during invasion (Tolia et al., 2005). Dimerisation of EBA175 in 
response to GPA binding may act as a signal to induce signalling within the merozoite. Binding of 
antibody fragments to GPA has also been shown to alter erythrocyte membrane deformability 
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(Chasis et al., 1985), in a process which may result from conformational changes within the 
cytoplasmic domain induced by binding to the extracellular region of GPA, raising the possibility that 
EBA175-GPA binding induces downstream alterations in both host and parasite which may 
contribute to the progress of the invasion process. 
Glycophorin B is structurally similar to glycophorin A with the exception of the cytoplasmic tail which 
is much shorter in GPB; it is encoded by a separate gene to GPA which probably arose by gene 
duplication of the original GYPA gene. It has a copy number of 170-200,000 copies per cell (
Glycophorin B (EBL-1) 
Reid ME, 
2012), 5-6 fold less than that of glycophorin A and exists both as homodimers and as part of 
heterodimers with GPA. Glycophorin B negative cells show moderate resistance (40-79% depending 
on the parasite strain studied) (Rayner et al., 2001, Gaur et al., 2003)) to malarial invasion but almost 
complete resistance following trypsin removal of glycophorin A which likely indicates a degree of 
functional redundancy in the roles of the parasite proteins involved in binding these similar 
glycophorins during merozoite attachment and invasion. Interestingly it has been hypothesised that 
glycophorin B may have arisen as a result of selective pressure to lose the EBA175 binding site on 
GPA (Salinas et al., 2014). 
In 2009, Mayer et al identified GPB as the receptor for the parasite protein erythrocyte binding 
ligand 1 (EBL-1) by demonstrating the inability of GPB null erythrocytes to adsorb this protein from 
P. falciparum culture supernatants (Mayer et al., 2009). These data were later corroborated through 
the screening of a P. falciparum cDNA phage display library using purified glycophorins, which also 
identified the binding site for GPB on EBL-1 (Li et al., 2012). As in the case of EBA175 binding to GPA, 
EBL-1 binding to erythrocytes is neuraminidase sensitive indicating that the binding site on GPB 
resides within a sialylated glycan epitope. 
Glycophorin C represents the third member of the erythrocyte glycophorin family, it comprises 128 
amino acids, 12 O linked glycans and a single N linked glycan, and is present at 135-143x10
Glycophorin C (EBA140) 
3
Reid ME, 2012
 copies 
per erythrocyte ( ). It resides within the junctional complex of proteins where it 
associates with the spectrin cytoskeleton via interactions with protein 4.1 and p55 (Alloisio et al., 
1993). GPC represents the erythrocyte receptor for the P. falciparum ligand EBA 140 (Lobo et al., 
2003, Maier et al., 2003), a homologue of EBA175 which binds to erythrocytes in a neuraminidase 
and trypsin sensitive but chymotrypsin insensitive manner. The precise nature of the binding site for 
EBA140 on GPC has proved difficult to determine unequivocally. Neuraminidase sensitivity indicates 
a dependence upon sialic acid for binding however this observation appears to be confounded by 
the inability of EBA140 to bind erythrocytes expressing the poorly glycosylated natural deletion 
variant of GPC termed Gerbich (prevalent within the population of the malaria endemic Melanesia 
region of Papua New Guinea (Patel et al., 2001)). Despite this, recent evidence has confirmed the 
importance of oligosaccharides and particularly the N glycan for EBA140 binding of GPC (Mayer et 
al., 2006, Rydzak et al., 2015). Sialylated residues attached to this glycosidic chain (resident on Asn8) 
and proposed to be modified in Gerbich erythrocytes represent the most likely binding site for the 
parasite ligand. As yet no alteration of erythrocyte membrane properties has been attributed to GPC 
binding that could indicate a role beyond surface attachment however antibody ligation of wild type 
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but not Gerbich erythrocytes was reported to induce phosphatidylserine exposure (Head et al., 
2005), a phenomenon also observed in Plasmodium infected erythrocytes (Eda and Sherman, 2002). 
Sialic Acid Independent Invasion Receptors 
Essential to the sialic acid independent pathway of P. falciparum invasion is the initially rhoptry 
localised protein PfRh4. Disruption of the gene encoding PfRh4 in a strain of normally sialic acid 
dependent parasites W2Mef abolishes the ability of this strain to switch invasion pathways to enable 
invasion of neuraminidase treated erythrocytes in which sialic acid has been enzymatically removed 
(
Complement Receptor 1 (PfRh4) 
Duraisingh et al., 2003a). In 2010, the erythrocyte receptor for PfRh4 was identified as complement 
receptor 1 (CR1) (Tham et al., 2010). CR1 is a widely expressed complement regulatory protein that 
binds C3b and C4b and mediates the clearance of immune complexes by splenic macrophages. It is a 
very large protein (220kDa in its most common variant) and is composed of a string of 30 short 
complement control protein (CCP) repeats which project 85nm from the surface of the erythrocyte 
plasma membrane (Moulds, 2010). The PfRh4 binding site has been mapped to the C3b/C4b binding 
domain located within the site encompassing CCP repeats 1-3 at the extreme N terminus of the 
protein (Tham et al., 2010). 
CR1 is expressed on a variety of blood cell types and mediates a range of immune functions. In 
erythrocytes, expression of CR1, which is low relative to other that observed on other blood cell 
types is variable, with up to 10 fold differences between individuals, ranging from as low as 1-200 up 
to 1200 copies per erythrocyte (Moulds, 2010). Erythrocytes from individuals with higher expression 
of CR1 exhibit increased merozoite, PfRh4 binding and sialic acid independent invasion rates 
respectively. Several studies have also correlated homozygosity (and even heterozygosity) for the 
CR1-L (CR1 low allele) with protection against severe malaria (Panda et al., 2012, Cockburn et al., 
2004, Fowkes et al., 2008). In interpretation of these data it is important to consider that CR1 also 
provides a binding site for the parasite rosetting ligand P. falciparum
Rowe et al., 1997
 erythrocyte membrane protein 
1 (PfEMP1) ( ) which is expressed on the surface of infected erythrocytes and thus 
the influence of CR1 levels on severity of clinical episodes of malaria is likely to be multifactorial. 
The precise role that PfRh4 binding to CR1 plays in facilitating the invasion process, as for the 
majority of the merozoite erythrocyte receptor interactions is unknown. Whilst there appears to be 
functional redundancy between the interaction of these two proteins and that between the EBA 
proteins and the sialic acid invasion pathway glycophorin receptors, the structural properties of CR1 
and GPA, B and C are very different. The glycophorins, each present at a copy number several orders 
of magnitude greater than CR1 are localised within multiprotein complexes with indirect linkage to 
the erythrocyte spectrin cytoskeleton. CR1 in contrast has not been identified to associate with the 
cytoskeleton or to exist as part of a larger complex. Nevertheless ligation of CR1 on uninfected 
erythrocytes by either antibodies or complement opsonised particles results in intracellular Ca2+ flux 
and a corresponding increase in membrane deformability associated with phosphorylation of β 
spectrin (Glodek et al., 2010) which speculatively could be exploited by the parasite as part of the 
invasion process. 
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The degree of functional redundancy between EBA and PfRh proteins is highlighted by the fact that 
the genes encoding all of these proteins can be genetically disrupted (reviewed in (
Basigin (PfRh5) 
Tham et al., 
2012). PfRh5 provides the sole exception to this rule, apparently providing an essential non 
redundant function at some stage of the blood stage parasite life cycle. Early work showed PfRh5 
binding to erythrocytes via an unknown glycosylated receptor resistant to chymotrypsin, trypsin and 
neuraminidase however the specific identity of the receptor remained uncovered (Baum et al., 
2009). In 2011 using a novel systematic screening approach optimised for the detection of low 
affinity interactions (AVEXIS - AVidity-based EXtracellular Interaction Screen) Crosnier et al identified 
the Ok blood group antigen basigin (CD147) as the much sought erythrocyte membrane protein 
receptor responsible for PfRh5 binding (Crosnier et al., 2011). 
Basigin (CD147) is a broadly expressed, highly glycosylated type I integral membrane protein that is a 
member of the immunoglobulin superfamily of proteins. Within the erythrocyte membrane it is 
present at approximately 3000 copies per cell (Reid ME, 2012) and exists as a homodimer in complex 
with two monomers of the monocarboxylate transporter 1 (MCT1) lactate transporter (Wilson et al., 
2002). As part of the biogenesis of the erythrocyte membrane during erythropoiesis, basigin is 
believed to act as a chaperone for MCT1 facilitating its delivery to the plasma membrane (Kirk et al., 
2000) . Basigin is not associated with the spectrin cytoskeleton and the majority of this protein 
expressed within the plasma membrane of orthochromatic erythroblasts is lost during the process of 
erythroblast enucleation (Griffiths et al., 2012). Whether the population that remains in complex 
with MCT1 in mature erythrocytes is vestigial at this stage or performs an additional unidentified 
function is unknown. It will be intriguing to see within the coming years whether the increased 
scrutiny of this protein uncovers features relating to its structure, properties or function under both 
basal and invasion conditions that account for its specific involvement in the merozoite invasion 
process. 
In addition to identifying basigin as the receptor for PfRh5 binding, employing a high throughput 
approach in which a pentamerised recombinant PfRh5 prey was used to screen a library comprised 
of 40 major erythrocyte membrane protein ectodomain,  Crosnier and colleagues were able to 
demonstrate that both soluble basigin and basigin antibodies potently inhibit invasion. The 
essentiality of basigin as a P. falciparum invasion receptor was further confirmed using an exciting 
approach made possible through advances within the erythropoiesis field that have enabled the in 
vitro culture of invasion susceptible red blood cells differentiated from haematopoietic stem cells. By 
transducing immature nucleated erythroid precursors with lentiviruses containing shRNA targeting 
BSG prior to subsequent differentiation, the authors were able to generate in vitro derived red blood 
cells exhibiting a 50-60% reduction in cell surface expression of basigin. In so doing they were able to 
monitor invasion of a novel red blood cell phenotype and confirm the reduced susceptibility of these 
cells to invasion by P. falciparum and hence the importance of the PfRh5-basigin interaction for this 
process. Additional work was able to establish the importance of a region of basigin that covers a 
naturally occurring variant of the protein harbouring the E92K Oka- mutation with erythrocytes from 
these rare donors demonstrating reduced susceptibility to invasion by P. falciparum. The crystal 
structure of PfRh5 in complex with basigin has since been reported providing detailed structural 
insight into the interaction between these two proteins (Wright et al., 2014). 
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Most excitingly, unlike in the case of other merozoite-erythrocyte receptor interactions which 
display varying strain dependent sensitivities to blocking, all detectable erythrocyte invasion by 
every P. falciparum strain tested was prevented by anti-basigin antibodies. The interaction between 
basigin and PfRh5 appears therefore to define a fundamentally distinct function from that of all 
previously identified EBA and PfRh protein interactions. This apparent cross strain dependence upon 
the binding of a single receptor-ligand pair has elevated the disruption of this interaction to the top 
of worldwide efforts for malaria therapeutic intervention and PfRh5 now represents the highest 
priority vaccination target. 
Semaphorin 7a (MTRAP
The TRAP family describes a group of proteins that facilitate linkage between target host cells and 
the actomyosin based molecular motors required to drive invasion of the various motile forms of 
malaria parasites including sporozoites, ookinetes and merozoites (
) 
Morahan et al., 2009). Each of 
these forms can be distinguished by expression of distinct TRAP family proteins. Whilst the 
importance of MTRAP, which is expressed on the surface of the blood stage invasive merozoite for 
successful erythrocyte invasion or growth, was illustrated by the inability to successfully disrupt the 
gene encoding this protein (Baum et al., 2006), the identity of the erythrocyte receptor for this 
parasite protein remained elusive for many years. In 2012 Bartholdson and colleagues, again 
employing the AVEXIS assay, demonstrated the identity of the human erythrocyte receptor for 
MTRAP as Semaphorin 7a (Bartholdson et al., 2012), an 80kDa GPI anchored glycosylated membrane 
protein also known as the John Milton Hagen (JMH) blood group antigen. Stoichiometric analysis 
indicates that MTRAP associates weakly with the dimeric Sema7a in a 1:1 ratio with two MTRAP 
monomers interacting with each Sema7a homodimer via the Sema domains. Naturally occurring 
polymorphisms within the extracellular domain of Sema7a did not affect the affinity of MTRAP 
binding and interestingly, the addition of antibodies to Sema7a did not inhibit merozoite invasion in 
in vitro invasion assays (Bartholdson et al., 2012). Although, Sema7a (CD108) has been shown to play 
diverse roles in neuronal and immune cells where it associates with integrins, neither the copy 
number nor function of Semaphorin 7a on erythrocytes is currently known hindering speculation 
regarding the relevance of the properties of this host cell protein to the function of this interaction. 
Studies of invasion phenotypes using erythrocytes from rare JMH negative individuals or from the 
complement sensitive erythrocytes of patients with paroxysomal nocturnal haemoglobinuria 
deficient in GPI anchored proteins may provide further insight into the timing and importance of this 
interaction for successful merozoite invasion. 
Band 3, together with glycophorin A, represents the most abundantly expressed protein within the 
erythrocyte plasma membrane, present at approximately 1x10
Band 3/GPA (MSP-1) 
6 Reid ME, 2012 copies per cell ( ). As 
an ankyrin-binding mediated tetramer it forms the core of a major multiprotein complex which also 
contains glycophorin A, protein 4.2 and components of the Rh (Rhesus protein) subcomplex, 
RhCe/D, RhAG, CD47, GPB and ICAM4 (Bruce et al., 2003) and provides the major site of vertical 
connectivity between plasma membrane and spectrin cytoskeleton required for maintenance of the 
erythrocyte structural integrity. In its dimeric state it resides within the junctional complex of 
proteins providing a supplementary site of cytoskeletal anchorage via its interaction with adducin 
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(Anong et al., 2009) and exists also as an additional population of more freely mobile dimers 
probably in association with GPA. 
Given its abundance, importance and interactions with other erythrocyte sites of malaria 
attachment, a role for band 3 in merozoite attachment and invasion has long been assumed to exist. 
It is only recently however that the potential nature of this role, during attachment at least, has 
begun to fully emerge. In 2003, Goel et al reported the identification of a sialic acid independent 
interaction of host and parasite proteins in vitro between two non-glycosylated extracellular regions 
of band 3 (within the regions covered by amino acids 720-761, and by 807-826) and fragments of the 
Major Merozoite Surface Protein (MSP1), MSP142 and MSP119 Goel et al., 2003( ). MSP1 is the most 
abundant protein on the surface of the merozoite (Holder and Freeman, 1984); it undergoes 
extensive proteolytic processing around the time of merozoite release following schizont rupture 
resulting in the generation of four proteolytic fragments of 83kDa, 30kDa, 38kDa and 42kDa which 
remain as a multisubunit complex on the surface of the merozoite (McBride and Heidrich, 1987) . 
Secondary processing of the 42kDa fragment results in the generation of a 33kDa and 19kDa 
fragment and whilst the majority of these fragments are shed from the merozoite surface, MSP119
Blackman et al., 1991
 
remains attached during the penetrative process of invasion( ). Recently, a 
yeast two hybrid study in which the 720-761 so called 5ABC peptide of band 3 was used as bait, 
identified an association between this extracellular region of band 3 and the C terminus of RhopH3 
(Baldwin et al., 2014), a P. falciparum protein which was in turn was shown to bind directly to 
MSP119
Band 3 associates directly with the equally abundant single transmembrane spanning EBA175 
receptor glycophorin A via its eighth transmembrane helix. The association of these two proteins at 
this location is marked by the presence of a well characterised blood group antigen Wrb. Earlier this 
year using phage display screening technology, Baldwin et al identified a region of the 83kDa 
fragment of MSP1 (a stably expressing 12kDa recombinant fragment) that bound to immobilised 
glycophorin A as well as native and neuraminidase treated erythrocytes (
. There is thus accumulating evidence for a role for band 3 as a binding site for the major 
multi component MSP complex to which RhopH3 has now been assigned. 
Baldwin et al., 2015). 
Interestingly this fragment also binds trypsin treated erythrocytes indicating binding to the trypsin 
insensitive 40 amino acid region of GPA close to the base of the extracellular domain of the protein. 
P. falciparum invasion is inhibited up to 40% in the presence of high concentrations of either MSP183 
or MSP112
The abundance within and specificity for the erythrocyte membrane of the band 3/GPA complex 
make it an ideal target for binding of merozoite proteins involved in initial pre-invasion adhesion, 
potentially enabling the parasite to attach at any site on the erythrocyte. It is easy to envision a 
scenario in which the merozoite has evolved in order to exploit association between its most 
abundantly expressed surface protein and that of the corresponding host cell equivalent in order to 
increase the chances of adhesion, which can take place regardless of the orientation of either cell. 
Band 3 exists as both tetramers and dimers, within at least two major multiprotein complexes and as 
populations both attached to the spectrin cytoskeleton (via ankyrin or adducin respectively) and 
mobile within the corrals imposed by the erythrocyte membrane cytoskeletal architecture. To what 
degree these different populations of band 3 (and associated GPA) represent the target for MSP1 
binding, the relevance of cytoskeletal association at these sites and the interplay between MSP1 
band 3/GPA interactions and subsequent binding of overlapping (in the case of EBA175-GPA) or 
. 
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sterically adjacent erythrocyte receptors during the rapid progression of committed invasion will all 
provide exciting avenues of future research. 
Invasion of the erythrocyte membrane by the apically orientated merozoite occurs via a tight 
junction which forms at the apposition of host and parasite membranes. Formation of this tight 
junction is mediated by the insertion of the merozoite RON (Rhoptry Neck Protein) complex protein 
RON2 into the erythrocyte membrane (
Kx (AMA1) 
Lamarque et al., 2011). AMA1 (Apical Membrane Antigen 1), 
a microneme protein which is secreted onto the surface of the merozoite binds to RON2 (Srinivasan 
et al., 2011) providing a tight and direct association between the invading parasite and host 
membrane. This remarkable mechanism enables the parasite to actually encode both ligand and 
receptor and with it provides an ingenious means by which to avoid the effects of evolutionary 
adaptation of host encoded proteins. Competitive inhibition of the RON2-AMA1 interaction by 
synthetic peptides does not prevent merozoite attachment to erythrocytes but potently inhibits 
invasion by preventing tight junction formation and internalisation (Richard et al., 2010, Weiss et al., 
2015). 
The site of tight junction formation within the erythrocyte membrane is an understandable source of 
interest within the malaria invasion research community. Although it is possible and perhaps even 
likely that RON complex components translocated to the cytoplasmic side of the erythrocyte 
membrane (Riglar et al., 2011) associate with host cell proteins to provide anchorage, no such 
associations have as yet been identified. A potential clue to the localisation of the tight junction was 
provided by the study of Kato et al (Kato et al., 2005). Using recombinantly expressed domains of 
AMA1 they showed that Domain III binds to trypsin treated wild type erythrocytes but not to 
erythrocytes null for the Kx protein suggesting that AMA1 binds to Kx as part of a process that also 
involves enzymatic exposure or modification of the erythrocyte surface protein. The authors also 
report reduced P. falciparum invasion of Kx null erythrocytes of the McLeod phenotype. It should be 
noted however that erythrocytes from these patients are severely acanthocytic (Galey et al., 1978) 
and possess in addition a myriad of additional membrane protein modifications (Tang et al., 1981) 
and altered properties (Ballas et al., 1990) that complicate interpretation of this effect. Whether this 
putative interaction plays an active role in tight junction formation/internalisation or occurs 
incidentally, the identification of a candidate erythrocyte receptor for a component of the tight 
junction, localised within the major junctional complex provides a useful starting point for efforts to 
characterise host-parasite interactions at this crucial structure. 
Receptors with Unknown Merozoite Binding Partners 
CD55 (Decay Accelerating factor or DAF) is a highly glycosylated 319 amino acid glycoprotein, it is 
comprised of a large extracellular domain containing four CCP repeats and a heavily O glycosylated 
stalk and is anchored to cholesterol rich domains or ‘lipid rafts’ within the extracellular face of the 
erythrocyte lipid bilayer by means of a GPI anchor (
CD55 
Lublin, 2005). CD55 is widely expressed on cells 
throughout the body but in erythrocytes is present at about 20,000 copies per cell (Reid ME, 2012). 
It serves as an inhibitor of autologous complement activation by preventing the assembly and 
accelerating the decay of C3 convertase and together with CD59 (Membrane Inhibitor of Reactive 
Lysis or MIRL), protects erythrocytes from complement mediated lysis. Absence of CD55 (and other 
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GPI linked proteins) on erythrocytes represents a characteristic phenotype used for the diagnosis of 
Paroxysomal Nocturnal Haemoglobinuria (PNH), a rare clonal disorder of haematopoietic stem cells 
that results from mutations in phosphatidylinositol glycan A
Earlier this year, a seminal study employed a high throughput forward genetic screening approach to 
the identification of erythrocyte membrane proteins involved in merozoite invasion. Using cultured 
red blood cells derived from haematopoietic stem cells transduced with a library of shRNAs to 
known blood group proteins they demonstrated that knock down of CD55 reduced susceptibility of 
host cells to P. falciparum invasion by up to 30%. Invasion of mature erythrocytes from the 
haematologically benign but rare naturally occurring CD55 null Inab phenotype by a variety of lab 
adapted P. falciparum strains and clinical isolates was almost completely abolished (
 (PIG-A), one of several enzymes 
required for the synthesis of GPI anchors. The absence of haematological phenotype in patients with 
a rare naturally occurring complete deficiency of CD55 alone (Inab phenotype) indicates that 
increased susceptibility of PNH erythrocytes to complement mediated lysis is not a direct result of 
the loss of CD55 expression on these cells. 
Egan et al., 
2015). Puzzlingly, the identification of CD55 as a strain transcendent mediator of parasite invasion is 
at odds with an earlier study that reported increased parasitemia within the CD55 negative 
population compared to CD55 positive erythrocytes within the same PNH patient (Pattanapanyasat 
et al., 2003). This is contrary to the observations of Egan et al who reported complete absence of 
invasion in erythrocytes from the rare CD55 null Inab individuals (Egan et al., 2015). Further 
investigation of this apparently contradictory increase in invasive susceptibility in the absence of 
CD55 in these patients may illuminate the role of additional codeficient GPI linked erythrocyte 
membrane proteins during the invasion process.  
Interestingly, Egan et al reported similar attachment of P. falciparum merozoites to CD55 null and 
wild type cells with subsequent detachment accounting for the defective invasion leading them to 
propose that CD55 may in fact be critical for committed tight junction formation rather than initial 
attachment. CD55 has also been reported to localise to the PVM together with other lipid raft 
associated proteins during invasion (Murphy et al., 2004). Binding of C3b to glycophorin A has been 
shown to result in the lateral confinement of CD55 via the formation of a cytoskeletally immobilised 
DAF-C3b-GPA-band 3 complex (Karnchanaphanurach et al., 2009). One interesting possibility 
therefore is that CD55 is recruited to membrane protein complexes at the site of invasion in 
response to binding of glycophorin A, for example by EBA175, positioning it for the establishment of 
an interaction with an as yet unidentified merozoite protein essential for committed invasion. 
Exploration of this hypothesis in concert with efforts to identify the merozoite binding partner for 
CD55 should represent an area of particular focus. 
 
In addition to the identification of CD55 as an erythrocyte receptor essential for P. falciparum 
invasion, Egan et al also demonstrated a 30% drop in parasitemia of in vitro cultured red blood cells 
with severe knockdown of CD44 (
CD44  
Egan et al., 2015). CD44 (H-CAM) is a widely expressed 85kDa 
glycoprotein that exists as multiple alternatively spliced variants. It provides a receptor for 
hyaluronic acid (HA), is present at approximately 6000-10,000 copies per cell (Anstee et al., 1991) 
and forms the Indian blood group in erythrocytes. CD44 has also been shown to bind ankyrin 
(Kalomiris and Bourguignon, 1988, Nunomura et al., 1997) and protein 4.1 (Nunomura et al., 1997), 
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with binding of the latter inhibiting binding to ankyrin, and also subject to regulation by calmodulin 
and Ca2+ Nunomura et al., 1997 in in vitro binding studies ( ). Influx of calcium into the erythrocyte, 
known to be associated with merozoite invasion could alter the affinity of CD44 for protein 4.1 
leading to a reconfiguration of its cytoplasmic domain interactions and potential conformational 
changes in the extracellular domain that could facilitate interactions with merozoite proteins. As in 
the case of CD55, identification of the merozoite binding partner as well as determination of the 
timing and nature of the disruption to the invasion process induced by the absence of CD44 will 
hopefully inform further work. 
Members of the Intercellular adhesion molecules (ICAMs) which (like the PfRh5 receptor basigin) 
form part of the immunoglobulin superfamily, are expressed on an array of cell types mediating or 
participating in a variety of cell-cell interactions. ICAM-4 was originally identified as the protein 
responsible for the erythrocyte LW (Landsteiner Wiener) blood group and later assigned to the ICAM 
family based on homology with other members. Its expression is restricted to the erythroid lineage 
residing within the Rh protein subcomplex (Rh, RhAG, GPB, CD47) within the larger tetrameric band 
3/ankyrin based multiprotein complex in mature erythrocytes. 
ICAM4  
Earlier this year, Bhalla et al reported binding of recombinant ICAM4 to merozoites accompanied by 
an 80% drop in invasion upon addition to in vitro invasion assays (Bhalla et al., 2015). Invasion assays 
performed in the presence of a synthetic protein (M5) that binds ICAM4 in erythrocytes resulted in 
dose dependent cross strain invasion inhibition of both untreated and neuraminidase treated 
erythrocytes, with microscopic analysis reportedly unaffected leading the authors to conclude that 
ICAM4 is important at a later stage of invasion post attachment. Erythrocytes completely deficient in 
ICAM4 have been reported – both individually (LWnull) and as part of the Rhnull phenotype. 
Interestingly, although relative invasion efficiency was not explicitly reported for untreated Rh null 
erythrocytes compared to wild type, Chung et al demonstrated efficient and even increased invasion 
of Rh null erythrocytes treated with a panel of proteases (Chung et al., 2008). Further work is 
warranted to clarify the involvement of ICAM4 during merozoite invasion. 
Whilst major strides have been made in the identification of receptor ligand interactions associated 
with merozoite binding to the erythrocyte, additional interactants undoubtedly remain. Even 
amongst the highly characterised EBL and PfRh families, receptors for merozoite proteins with 
recognised capacity to bind the erythrocyte remain unidentified. Chief amongst these are the sialic 
acid dependent receptors termed W, Y and Z, binding partners for EBA181(
Merozoite Proteins with Unidentified Erythrocyte Receptors 
Gilberger et al., 2003), 
PfRh1 (Rayner et al., 2001, Triglia et al., 2005) and PfRh2a/b (Duraisingh et al., 2003b) respectively 
and for which protease sensitivity profiles have long been characterised. Although the capacity for 
genetic disruption of each of these P. falciparum genes indicates non crucial or redundant 
functionality during the invasion process it will be fascinating to observe whether any of the 
erythrocyte proteins with demonstrated (Egan et al., 2015, Bhalla et al., 2015) or speculated (Storry 
et al., 2013) involvement in parasite binding represent targets for binding of these prominent 
parasite adhesins. 
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A detailed understanding of the sequence of specific protein interactions that occur between host 
and parasite proteins during attachment and invasion and how these correlate with the 
characteristic stages of the process outlined in Figure 1 is crucial to efforts to determine the 
molecular mechanism by which merozoite invasion of the red blood cell occurs from both a parasite 
and host perspective. Whilst significant insight has been derived from the localisation of specific 
proteins within compartments of the merozoite, the rapidity of the invasion process remains a major 
barrier to the detailed study of this process. Earlier this year Weiss et al published an extensive study 
in which they used live cell microscopy to perform a detailed visual characterisation of merozoite 
invasion (
Sequence of merozoite-erythrocyte protein interactions during invasion 
Weiss et al., 2015). By using a combination of inhibitors, protease treatments and parasite 
strains with defined invasion pathways they were able to develop a proposed model that describes 
the sequence of interactions that occur during P. falciparum invasion of an erythrocyte. With 
reference to the identities of erythrocyte receptors discussed in this review this can be summarised 
as the likely sequential interaction of 1) MSP1 with band 3/GPA (with accompanying weak 
deformation of the erythrocyte membrane), 2) the redundant interaction of EBA/PfRh ligands with 
glycophorins or CR1 associated with a strong merozoite motor dependent erythrocyte deformation, 
3) PfRh5 binding to basigin resulting in formation of a pore connecting parasite and host and 4) 
establishment of an AMA1-RON2 interaction mediated tight junction within the erythrocyte 
membrane at unknown site with as yet speculative links to CD55 (Egan et al., 2015) or the junctional 
complex (Kato et al., 2005). 
This review summarises a body of work that spans in excess of 40 years. During this time huge 
strides have been made in our understanding of the interactions that occur at the interface of 
malaria parasite and erythrocyte host. From early studies characterising protease sensitivity of 
erythrocytes to P.falciparum invasion in the 1970s and 80’s to cutting edge screening approaches of 
recombinant protein libraries and the generation of haematopoietic stem cell derived novel red 
blood phenotypes as recently as this year, an array of complementary approaches have been 
employed over the years to identify the sites of malaria parasite attachment on the surface of the 
red blood cell (summarised in Figure 2). Identification of these receptors and of the corresponding 
P.falciparum proteins by which they are bound continues to inform our understanding of the 
mechanism of merozoite attachment and invasion of the erythrocyte membrane. Nevertheless many 
important questions still remain: Why are specific proteins on the surface of the erythrocyte 
targeted for attachment over others? Does this relate purely to structural characteristics of the host 
proteins? It is perhaps unsurprising that many of the erythrocyte proteins targeted are those that 
extend furthest from the surface of the plasma membrane. GPA,B,C, CR1, basigin, CD44 and ICAM4 
are all single transmembrane helix proteins, Sema 7a and CD55 are attached to the plasma 
membrane via a GPI anchor – although these proteins vary considerably in size (contrast the 85nm 
CR1 with the 70 amino acid extracellular domain of GPA) (
Perspectives 
Bartholdson et al., 2013), all possess 
exposed flexible N terminal extracellular domains which likely facilitate interactions with the 
proteins expressed on the surface of the merozoite. At present, with the exception of the band 3-
MSP1 association (itself seemingly dependent on a dual interaction with GPA) and possibly Kx-
AMA1, no associations of merozoite proteins with extracellular domains of multi- transmembrane 
helix proteins have been reported. Whether this is indeed due to the reduced accessibility of 
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extracellular domains within these proteins or merely reflects the current practical difficulties 
associated with expression and characterisation of these proteins (Bartholdson et al., 2013), with 
additional important associations still to be identified remains to be determined. Alternatively, does 
the abundance and cell lineage restricted expression of specific proteins, for example band 3 and the 
glycophorins, alone account for their involvement in the early attachment events of the invasion 
process? Or are specific receptors involved at different stages of the invasion process based on more 
functional characteristics beneath the surface of the exposed extracellular domains?  
Here, in particular there remains huge scope for further work. Consideration of these receptors, not 
as isolated sites for binding but in their native red blood cell membrane environment as part of 
multiprotein complex assemblies (Mankelow et al., 2012), cytoskeletally associated and with the 
capacity for dynamic rearrangement and modification is crucial to understanding the mechanisms 
that link merozoite attachment with active penetrative invasion. Many of the erythrocyte membrane 
proteins targeted for binding by merozoite proteins are involved either directly or indirectly in 
important red blood cell processes that range from regulation of membrane deformability to 
mediation of immune clearance. The degree to which these normal functions may be co-opted by 
the parasite to facilitate invasion is a fascinating area for future work. In this context, understanding 
the relevance of cytoskeletal linkage of specific receptors (and its absence for others), its 
establishment and disruption as part of the invasion process, is also key. As is an active appreciation 
of the effect that binding can have not just on adjacent proteins but at distant sites through 
modulation of cell signalling and through alteration of membrane biophysical properties. In recent 
years, the erythrocyte membrane biology field has been rejuvenated by developments in the in vitro 
culture and manipulation of erythroid cells. Undoubtedly significant challenges exist in the 
application of these technologies to more mechanistic studies of malaria invasion. However this 
author is hopeful that the substantial knowledge gained from identification of binding sites at the 
extracellular face of the erythrocyte and outlined in this review can be exploited to uncover the 
detailed and complex mechanism that underlies merozoite attachment and invasion of the 
erythrocyte membrane. 
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What is Known? Plasmodium falciparum merozoite invasion of red blood cells is mediated via 
specific binding to prominent erythrocyte membrane proteins. Different invasion pathways are 
characterised by functionally redundant binding to erythrocyte proteins that characterise sialic acid 
dependent and independent invasion pathways. 
Boxes 
What is New? Exciting high throughput approaches employing novel screening approaches of 
recombinant protein libraries and invasion of in vitro derived red blood cells derived from genetic 
manipulation of haematopoietic stem cells have identified new erythrocyte protein receptors with 
essential roles in invasion. 
What are the Main Questions for Future Work? Why are specific erythrocyte membrane proteins 
targets for merozoite binding? How are the intrinsic properties and erythrocyte functions of 
individual receptor proteins exploited or coopted by merozoite binding at different stages of the 
attachment and invasion process? How does binding to extracellular receptors facilitate the host 
cytoskeletal disruption required for merozoite penetration of the erythrocyte? 
 
Figure 1 Scheme depicting current model of merozoite invasion of the erythrocyte membrane. 1) 
Merozoites attach to the erythrocyte membrane in a random orientation most commonly ‘side on’ 
2) Reorientation of the merozoite occurs such that the apical tip is in direct contact with the host 
membrane 3) A tight junction is established at the interface of merozoite and erythrocyte 
membrane likely facilitated by the association of EBL and PfRh proteins (secreted to the merozoite 
surface from their initial micronemal and rhoptry localisation) with their corresponding erythrocyte 
receptors. This process also involves insertion of the RON complex of parasite proteins into the host 
cell membrane 4) Penetrative force provided by the parasite actin myosin motor drives active 
invasion into a parasitophorous vacuole compartment believed to be created by secretion of the 
rhoptries into the host cell 5) The erythrocyte membrane is resealed completing the invasion 
process. Invasion process timings are taken from (
Figure Legends 
Harvey et al., 2012, Weiss et al., 2015). 
Figure 2 Schematic representation of human erythrocyte Plasmodium falciparum ‘invasion 
receptors’ labelled with corresponding merozoite binding proteins where known. Binding sites for P. 
falciparum proteins, where known, are indicated in red. Receptor dimensions are not to scale. 
 


